Immunohistochemical study was performed to evaluate the expression of Bcl-2 family proteins (Bcl-2, Bax, and Bad) in Walker 256 carcinosarcoma cells after implantation into the thigh muscle of male Wistar rats (106 cells). The experiment was conducted under conditions of spontaneous tumor development and individual or combined treatment with melatonin and cyclophosphamide. The use of melatonin as monotherapy or in combination with cyclophosphamide was followed by a signifi cant decrease in Bcl-2 expression in carcinosarcoma cells. The Bcl-2/Bax and Bcl-2/Bad ratio was signifi cantly reduced under these conditions (particularly after combined treatment with cytostatic drugs). These changes were accompanied by a signifi cant (by 93.61%) decrease in the volume of transplantable tumor on day 14. Daily treatment with melatonin was accompanied by signifi cant changes in the structure of Walker 256 carcinosarcoma. It was manifested in the formation of connective tissue septa and pseudofollicles.
Similar content being viewed by others
References
N. N. Belushkina, Vestn. Ros. Akad. Med. Nauk, No. 10, 15–20 (2008).
S. Glants, Medical and Biological Statistics [in Russian], Moscow (1999).
I. I. Khegai, N. A. Popova, L. S. Ganilova, et al., Byull. Eksp. Biol. Med., 145, No. 1, 88–90 (2008).
V. N. Ellinidi, N. V. Anikiev, and N. A. Maksimov, Practical Immunohistochemistry. Methodical Recommendations [in Russian], St. Petersburg (2002).
A. S. Belzacq, H. L. Vieira, F. Verrier, et al., Cancer Res., 63, No. 2, 541–546 (2003).
A. M. Chinaiyan, K. Orth, K. O’Rourke, et al., J. Biol. Chem., 271, No. 9, 4573–4576 (1996).
J. Choi, K. Choi, E. N. Benveniste, et al., Cancer Res., 65, No. 13, 5554–5560 (2005).
V. T. De Vita, Coolloque INSERM, 75, 863 (1988).
Y. Ionov, H. Yamamoto, S. Krajewski, et al., Proc. Natl. Acad. Sci. USA, 97, No. 20, 10,872–10,877 (2000).
M. D. Jacobson, Curr. Biol., 7, No. 5, R277–R281 (1997).
P. Kumar, I. K. Coltas, B. Kumar, et al., Cancer Res., 67, No. 3, 1193–1202 (2007).
H. Lesnicar and M. Budihna, Radiol. Ingosl., 23, 295 (1989).
P. H. Schlesinger, A. Gross, X. M. Yin, et al., Proc. Natl. Acad. Sci. USA, 94, No. 21, 11,357–11,362 (1997).
T. E. Vaskivuo, F. Stenback, and J. S. Tapanainen, Cancer, 95, No. 7, 1463–1471 (2002).
K. G. Zecchin, A. L. Seidinger, M. R. Chiaratti, et al., J. Bioenerg. Biomembr., 39, No. 2, 186–194 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, No. 10, pp. 455-460, October, 2009
Rights and permissions
About this article
Cite this article
Ovsjanko, E.V., Lushnikova, E.L., Larionov, P.M. et al. Immunohistochemical Study for the Expression of Bcl-2 Family Proteins in Walker 256 Carcinosarcoma Cells under the Influence of Cytostatic Drugs. Bull Exp Biol Med 148, 650–655 (2009). https://doi.org/10.1007/s10517-010-0787-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-010-0787-5